Zhaochun Li
@zlii0273fkvxooxupo• Nov 12, 2022
BPS2032 S2 2022: HPLC METHOD DEVELOPMENT FLOW CHART
categorised in CHEMICAL , MECHANICAL, OTHER OR BOTH
(legend needed) allows to
Relevant Illustrations and theory are cleverly inserted for the user's information
BPS2032 S2 2022: HPLC METHOD DEVELOPMENT FLOW CHARTlms.monash.edu
Zhaochun Li
@zlii0273fkvxooxupo• Nov 3, 2022
GPCR - structure/function W4: Intracellular loops and tail
fferent structural modifications enable G-proteins to do what they do
GPCR - structure/function W4: Intracellular loops and taillms.monash.edu
Zhaochun Li
@zlii0273fkvxooxupo• Nov 3, 2022
GPCR - structure/function W4: Extracellular loops
GPCRs to G-proteins involves specific regions of the recepto
introduces the ligand to the appropriate binding site within the GPCR structure
N-terminal tip is cleaved by an enzyme (serum serine proteinase),
GPCR - structure/function W4: Extracellular loopslms.monash.edu
Zhaochun Li
@zlii0273fkvxooxupo• Nov 3, 2022
GPCR - structure/function: Example: Chemokines
sequestration and modulation of their local concentratio
binds to one N-terminal peptide
second N-terminal peptide binds to the second monomer leading to the formation of a symmetric 2:2 complex
GPCR - structure/function: Example: Chemokineslms.monash.edu
Zhaochun Li
@zlii0273fkvxooxupo• Nov 3, 2022
Antagonism: Non-competitive antagonism
Negative allosteric modulators
increase or decrease receptor activity (pos
ight look like a competitive irreversible antagonist.
Antagonism: Non-competitive antagonismlms.monash.edu
Zhaochun Li
@zlii0273fkvxooxupo• Nov 3, 2022
Antagonism: Competitive antagonism
gonists, k-1/k+1 can be expressed as the equilibrium/dissociation constant.
oth have affinity for receptors!
So you can use the same equation to describe competitive (reversible) antagonist binding to a recepto
Antagonism: Competitive antagonismlms.monash.edu
Zhaochun Li
@zlii0273fkvxooxupo• Nov 3, 2022
Antagonism: Types of antagonism
allergen binds to sensitized mast cells (and basophils) it causes a massive degranulation
Antagonism: Types of antagonismlms.monash.edu
Zhaochun Li
@zlii0273fkvxooxupo• Nov 2, 2022
Agonists in context: affinity, potency and efficacy: Graphical representation of agonist-receptor action
interesting points will all be squashed in close to the Y-axis
computing the EC50 (th
Agonists in context: affinity, potency and efficacy: Graphical representation of agonist-receptor actionlms.monash.edu
Zhaochun Li
@zlii0273fkvxooxupo• Nov 2, 2022
Agonists in context: affinity, potency and efficacy: Mass action and the receptor agonist complex
this pathway activates PLC which increases production of the second messengers IP3 and DAG, eventually leading to the release of Ca2+ from intracellular stores
n can neatly explain the interaction of PE with the α1-adrenoceptor (we'll cover this in excruciating detail in the lectures), b
Agonists in context: affinity, potency and efficacy: Mass action and the receptor agonist complexlms.monash.edu
Zhaochun Li
@zlii0273fkvxooxupo• Nov 1, 2022
BPS2022_Mid-semester test: Attempt review
measure mRNA levels.
main advantages, and limitation, of measuring mRNA levels
BPS2022_Mid-semester test: Attempt reviewlms.monash.edu